Pages
Google yanks apps that could take over your phone
John Moe Mar 3, 2011
Dozens of apps for Android devices have been taken out of circulation by Google. They were apps that can take control of your phone without your even realizing it.
Breakthrough in circuitry efficiency
John Moe Mar 1, 2011
Hewlett-Packard scientists think they've come up with a way to dramatically reduce the amount of energy needed to run a computer. Computing power...
Scientists use sensors to get close-ups of wild animals; now you can see all this online
John Moe Feb 28, 2011
The Smithsonian has launched a new website that features more than 200,000 photos taken by researchers from automated cameras. The cameras have...
Schools using GPS devices to track students
John Moe Mar 1, 2011
A school district in Anaheim, California is the latest to distribute GPS devices to habitually truant students. But what role does a private company in Texas have in monitoring the students?
Scientists build an anti-laser, you guys!
John Moe Feb 18, 2011
A team of Yale University scientists have built a device that can absorb a laser beam entirely....
FDA approves wider Lap-Band use for less obese
Eve Troeh Sep 22, 2011
The Food and Drug Administration will allow cosmetic drug and device maker Allergan Inc. to market its stomach-restricting Lap-Band to millions of new patients -- patients who are less obese than those currently using the device. Eve Troeh has more.
Battle lines being drawn in fight against online piracy
John Moe Feb 16, 2011
The Senate Judiciary Committee holds hearings today on how best to combat online piracy. We talk to the chairman of that committee, Sen. Patrick Leahy (D-Vt.) about the aggressive approach he would like to see.
Sanofi-Aventis to pay more than $20 bil. for Genzyme
Steve Chiotakis Sep 22, 2011
French pharmaceutical company Sanofi-Aventis will pay more than $20.1 billion for U.S. biotech firm Genzyme. Sanofi will pay $74 per Genzyme share once the deal closes in the second quarter of 2011.
Pharma deal: French Sanofi-Aventis to buy U.S. Genzyme
Eve Troeh Sep 22, 2011
Wednesday brought an end to the long-awaited deal between French pharmaceutical company Sanofi-Aventis and the U.S. biotech firm Genzyme. Sanofi will buy Genzyme for at least $20.1 billion. But the number could go higher if Genzym's drugs-in-development succeed when they go to market, as Eve Troeh explains.
Now that you're used to .com and .net, get ready for .everythingelse
John Moe Sep 22, 2011
The governing body that controls web domain names is preparing for what it calls a land rush. Soon, you might be seeing not just .com and .net but .eco, .flowers, .god, .gay, and dot just about anything else you can think of.
